{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T13:47:47Z","timestamp":1758635267758,"version":"3.38.0"},"reference-count":132,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.cld.2011.08.007","type":"journal-article","created":{"date-parts":[[2011,11,14]],"date-time":"2011-11-14T21:13:32Z","timestamp":1321305212000},"page":"821-843","source":"Crossref","is-referenced-by-count":7,"title":["Medical Management of the Liver Transplant Recipient"],"prefix":"10.1016","volume":"15","author":[{"given":"R. Todd","family":"Stravitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel E.","family":"Carl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane M.","family":"Biskobing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.cld.2011.08.007_bib1","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1053\/jlts.2001.27084","article-title":"Analysis of causes of death in liver transplant recipients who survived more than 3 years","volume":"7","author":"Pruthi","year":"2001","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.cld.2011.08.007_bib2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/01.TP.0000100685.70064.90","article-title":"Is there disparity between risk and incidence of cardiovascular disease after liver transplant?","volume":"77","author":"Neal","year":"2004","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.cld.2011.08.007_bib3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0002-9610(02)00826-7","article-title":"Immunosuppression impact on long-term cardiovascular complications after liver transplantation","volume":"183","author":"Rabkin","year":"2002","journal-title":"Am J Surg"},{"issue":"1","key":"10.1016\/j.cld.2011.08.007_bib4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1399-0012.1997.tb00782.x","article-title":"Cardiovascular risk factors in long-term follow-up after orthotopic liver transplantation","volume":"11","author":"Guckelberger","year":"1997","journal-title":"Clin Transplant"},{"issue":"5","key":"10.1016\/j.cld.2011.08.007_bib5","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/00007890-200003150-00018","article-title":"Long-term medical complications in patients surviving\u00a0> or\u00a0= 5 years after liver transplant","volume":"69","author":"Sheiner","year":"2000","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.cld.2011.08.007_bib6","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/01.TP.0000158738.00927.65","article-title":"Mechanisms of hypertension after liver transplantation","volume":"79","author":"Neal","year":"2005","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.cld.2011.08.007_bib7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/01.HYP.22.2.257","article-title":"De novo hypertension after liver transplantation","volume":"22","author":"Textor","year":"1993","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.cld.2011.08.007_bib8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/hep.510300112","article-title":"Systemic and splanchnic hemodynamic changes after liver transplantation for cirrhosis: a long-term prospective study","volume":"30","author":"Piscaglia","year":"1999","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2011.08.007_bib9","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2011.08.007_bib10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1161\/01.CIR.71.3.487","article-title":"Long-term hemodynamic follow-up of cardiac transplant patients treated with cyclosporine and prednisone","volume":"71","author":"Greenberg","year":"1985","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.cld.2011.08.007_bib11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0895-7061(99)00171-5","article-title":"Hypertension after liver transplantation: a predictive role for pretreatment hemodynamics and effects of isradipine on the systemic and renal circulations","volume":"13","author":"Taler","year":"2000","journal-title":"Am J Hypertens"},{"issue":"5","key":"10.1016\/j.cld.2011.08.007_bib12","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/jlts.2000.9737","article-title":"Posttransplantation hypertension related to calcineurin inhibitors","volume":"6","author":"Textor","year":"2000","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.cld.2011.08.007_bib13","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/ki.1993.101","article-title":"Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion","volume":"43","author":"Ruggenenti","year":"1993","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.cld.2011.08.007_bib14","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1681\/ASN.2007040394","article-title":"Chronic kidney disease after nonrenal solid-organ transplantation","volume":"18","author":"Bloom","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2011.08.007_bib15","first-page":"1214","article-title":"Role of endothelin-1 and nitric oxide bioavailability in transplant-related vascular injury: comparative effects of rapamycin and cyclosporine","volume":"114","author":"Ramzy","year":"2006","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cld.2011.08.007_bib16","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1046\/j.1523-1755.2000.00838.x","article-title":"Renal hemodynamics and pharmacokinetics of bosentan with and without cyclosporine A","volume":"57","author":"Binet","year":"2000","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.cld.2011.08.007_bib17","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1097\/HJH.0b013e32833c20eb","article-title":"Differential effects of acute and sustained cyclosporine and tacrolimus on sympathetic nerve activity","volume":"28","author":"Klein","year":"2010","journal-title":"J\u00a0Hypertens"},{"issue":"11","key":"10.1016\/j.cld.2011.08.007_bib18","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1097\/00004872-199311000-00008","article-title":"Cyclosporin-induced hypertension precedes renal dysfunction and sodium retention in man","volume":"11","author":"Sturrock","year":"1993","journal-title":"J\u00a0Hypertens"},{"issue":"9308","key":"10.1016\/j.cld.2011.08.007_bib19","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(02)07875-3","article-title":"Efficacy and safety of tacrolimus compared with cyclosporin microemulsion in renal transplantation: a randomised multicentre study","volume":"359","author":"Margreiter","year":"2002","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.cld.2011.08.007_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/lt.500030101","article-title":"Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK506)","volume":"3","author":"Canzanello","year":"1997","journal-title":"Liver Transpl Surg"},{"issue":"1","key":"10.1016\/j.cld.2011.08.007_bib21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0163-7258(02)00297-8","article-title":"Mechanisms involved in the side effects of glucocorticoids","volume":"96","author":"Schacke","year":"2002","journal-title":"Pharmacol Ther"},{"issue":"19","key":"10.1016\/j.cld.2011.08.007_bib22","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2011.08.007_bib23","doi-asserted-by":"crossref","first-page":"I220","DOI":"10.1161\/01.HYP.23.1_Suppl.I220","article-title":"Systemic and renal effects of nifedipine in cyclosporine-associated hypertension","volume":"23","author":"Textor","year":"1994","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.cld.2011.08.007_bib24","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/01.TP.0000116418.78963.DC","article-title":"Hemodynamic effects of amlodipine, bisoprolol, and lisinopril in hypertensive patients after liver transplantation","volume":"77","author":"Neal","year":"2004","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.cld.2011.08.007_bib25","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.transproceed.2005.01.066","article-title":"Comparison between nifedipine and carvedilol in the treatment of de novo arterial hypertension after liver transplantation: preliminary results of a controlled clinical trial","volume":"37","author":"Galioto","year":"2005","journal-title":"Transplant Proc"},{"issue":"10","key":"10.1016\/j.cld.2011.08.007_bib26","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMoa021744","article-title":"Chronic renal failure after transplantation of a nonrenal organ","volume":"349","author":"Ojo","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.cld.2011.08.007_bib27","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1093\/ndt\/gfl247","article-title":"Chronic kidney disease post-liver transplantation","volume":"21","author":"O\u2019Riordan","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"10.1016\/j.cld.2011.08.007_bib28","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/lt.21821","article-title":"Renal outcomes after liver transplantation in the model for end-stage liver disease era","volume":"15","author":"Sharma","year":"2009","journal-title":"Liver Transpl"},{"issue":"9","key":"10.1016\/j.cld.2011.08.007_bib29","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/lt.20445","article-title":"Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation","volume":"11","author":"Campbell","year":"2005","journal-title":"Liver Transpl"},{"issue":"7","key":"10.1016\/j.cld.2011.08.007_bib30","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1053\/jlts.2003.50113","article-title":"Independent risk factors and natural history of renal dysfunction in liver transplant recipients","volume":"9","author":"Pawarode","year":"2003","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.cld.2011.08.007_bib31","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/08860220600683607","article-title":"Predictive factors for chronic renal failure one year after orthotopic liver transplantation","volume":"28","author":"Guitard","year":"2006","journal-title":"Ren Fail"},{"issue":"12","key":"10.1016\/j.cld.2011.08.007_bib32","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1097\/00007890-200112270-00012","article-title":"End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment","volume":"72","author":"Gonwa","year":"2001","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.cld.2011.08.007_bib33","doi-asserted-by":"crossref","first-page":"735","DOI":"10.7326\/0003-4819-144-10-200605160-00007","article-title":"Brief communication: glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation","volume":"144","author":"McGuire","year":"2006","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.cld.2011.08.007_bib34","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1111\/j.1600-6143.2006.01403.x","article-title":"BK virus infection in transplant recipients: an overview and update","volume":"6","author":"Randhawa","year":"2006","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.cld.2011.08.007_bib35","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00007890-199807150-00010","article-title":"Chronic renal failure following liver transplantation: a retrospective analysis","volume":"66","author":"Fisher","year":"1998","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.cld.2011.08.007_bib36","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.transproceed.2005.02.037","article-title":"Modulation factors of oxidative status in stable renal transplantation","volume":"37","author":"Moreno","year":"2005","journal-title":"Transplant Proc"},{"issue":"11","key":"10.1016\/j.cld.2011.08.007_bib37","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1097\/00007890-200112150-00019","article-title":"Transforming growth factor-beta1 and tumor growth factor-beta-inducible gene-H3 in nonrenal transplant cyclosporine nephropathy","volume":"72","author":"Langham","year":"2001","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.cld.2011.08.007_bib38","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.transproceed.2005.12.056","article-title":"Inhibition of the renin angiotensin system decreases fibrogenic cytokine expression in tacrolimus nephrotoxicity in rats","volume":"38","author":"Deniz","year":"2006","journal-title":"Transplant Proc"},{"issue":"2","key":"10.1016\/j.cld.2011.08.007_bib39","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00007890-200001270-00019","article-title":"Experience with daclizumab in liver transplantation: renal transplant dosing without calcineurin inhibitors is insufficient to prevent acute rejection in liver transplantation","volume":"69","author":"Hirose","year":"2000","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.cld.2011.08.007_bib40","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/lt.20490","volume":"11","author":"Yoshida","year":"2005","journal-title":"Liver Transpl"},{"issue":"11","key":"10.1016\/j.cld.2011.08.007_bib41","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1093\/ndt\/gfh462","article-title":"Blockade of the renin-angiotensin system increases graft survival in patients with chronic allograft nephropathy","volume":"19","author":"Artz","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.cld.2011.08.007_bib42","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/lt.20926","article-title":"Switch to 1.5 grams MMF monotherapy for CNI-related toxicity in liver transplantation is safe and improves renal function, dyslipidemia, and hypertension","volume":"13","author":"Orlando","year":"2007","journal-title":"Liver Transpl"},{"issue":"7","key":"10.1016\/j.cld.2011.08.007_bib43","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/lt.21185","article-title":"Short-term induction therapy with anti-thymocyte globulin and delayed use of calcineurin inhibitors in orthotopic liver transplantation","volume":"13","author":"Soliman","year":"2007","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.cld.2011.08.007_bib44","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.TP.0000165118.00988.D7","article-title":"Mycophenolate mofetil for renal dysfunction in liver transplant recipients on cyclosporine or tacrolimus: randomized, prospective, multicenter pilot study results","volume":"80","author":"Reich","year":"2005","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.cld.2011.08.007_bib45","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1053\/jlts.2003.50026","article-title":"Sirolimus monotherapy in nephrotoxicity due to calcineurin inhibitors in liver transplant recipients","volume":"9","author":"Nair","year":"2003","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.cld.2011.08.007_bib46","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/lt.21429","article-title":"Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens","volume":"14","author":"DuBay","year":"2008","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.cld.2011.08.007_bib47","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/TP.0b013e3181fe131b","article-title":"Switching to sirolimus-based immune suppression after liver transplantation is safe and effective: a single-center experience","volume":"91","author":"Harper","year":"2011","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.cld.2011.08.007_bib48","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/ki.2010.268","article-title":"Sirolimus for calcineurin inhibitors in organ transplantation: contra","volume":"78","author":"Cravedi","year":"2010","journal-title":"Kidney Int"},{"issue":"26","key":"10.1016\/j.cld.2011.08.007_bib49","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1056\/NEJM200312253492617","article-title":"Chronic renal failure after transplantation of a nonrenal organ","volume":"349","author":"Gonwa","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.cld.2011.08.007_bib50","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/lt.21010","article-title":"Risk factors for new-onset diabetes mellitus following liver transplantation and impact of hepatitis C infection: an observational multicenter study","volume":"13","author":"Saliba","year":"2007","journal-title":"Liver Transpl"},{"issue":"9","key":"10.1016\/j.cld.2011.08.007_bib51","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1097\/TP.0b013e3181d2fec1","article-title":"Risk factors for new-onset diabetes mellitus in adult liver transplant recipients, an analysis of the Organ Procurement and Transplant Network\/United Network for Organ Sharing database","volume":"89","author":"Kuo","year":"2010","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.cld.2011.08.007_bib52","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0168-8278(96)80329-1","article-title":"Diabetes mellitus after liver transplantation: prevalence and predictive factors","volume":"25","author":"Navasa","year":"1996","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2011.08.007_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diabet.2010.09.003","article-title":"New-onset diabetes after transplantation: risk factors and clinical impact","volume":"37","author":"Rakel","year":"2011","journal-title":"Diabetes Metab"},{"issue":"6","key":"10.1016\/j.cld.2011.08.007_bib54","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/00007890-200109270-00015","article-title":"Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality","volume":"72","author":"Baid","year":"2001","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.cld.2011.08.007_bib55","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/jhep.2001.29134","article-title":"Outcome of liver transplantation in patients with diabetes mellitus: a case-control study","volume":"34","author":"John","year":"2001","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.cld.2011.08.007_bib56","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1053\/jlts.2002.34638","article-title":"Outcome of patients with new-onset diabetes mellitus after liver transplantation compared with those without diabetes mellitus","volume":"8","author":"John","year":"2002","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1016\/j.cld.2011.08.007_bib57","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/j.1600-6143.2009.02642.x","article-title":"Insulin resistance, serum adipokines and risk of fibrosis progression in patients transplanted for hepatitis C","volume":"9","author":"Veldt","year":"2009","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.cld.2011.08.007_bib58","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1600-6143.2007.01749.x","article-title":"Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus","volume":"7","author":"Vincenti","year":"2007","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1016\/j.cld.2011.08.007_bib59","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/01.TP.0000157870.21957.E5","article-title":"Tacrolimus and posttransplant diabetes mellitus in renal transplantation","volume":"79","author":"van Hooff","year":"2005","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.cld.2011.08.007_bib60","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1016\/j.transproceed.2010.04.045","article-title":"Sirolimus in liver transplant recipients: a large single-center experience","volume":"42","author":"Vivarelli","year":"2010","journal-title":"Transplant Proc"},{"issue":"5","key":"10.1016\/j.cld.2011.08.007_bib61","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/01.TP.0000114283.04840.3A","article-title":"Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation","volume":"77","author":"Gado-Borrego","year":"2004","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.cld.2011.08.007_bib62","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1399-0012.2005.00359.x","article-title":"Guidelines for the treatment and management of new-onset diabetes after transplantation","volume":"19","author":"Wilkinson","year":"2005","journal-title":"Clin Transplant"},{"issue":"6","key":"10.1016\/j.cld.2011.08.007_bib63","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/lt.20439","article-title":"New-onset diabetes after liver transplantation: from pathogenesis to management","volume":"11","author":"Marchetti","year":"2005","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.cld.2011.08.007_bib64","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2337\/dc08-9025","article-title":"Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"32","author":"Nathan","year":"2009","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.cld.2011.08.007_bib65","doi-asserted-by":"crossref","first-page":"540","DOI":"10.4158\/EP.15.6.540","article-title":"Statement by an American Association of Clinical Endocrinologists\/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control","volume":"15","author":"Rodbard","year":"2009","journal-title":"Endocr Pract"},{"issue":"5","key":"10.1016\/j.cld.2011.08.007_bib66","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4158\/EP08331.RAR","article-title":"Glucocorticoid-induced hyperglycemia","volume":"15","author":"Clore","year":"2009","journal-title":"Endocr Pract"},{"issue":"4","key":"10.1016\/j.cld.2011.08.007_bib67","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/lt.500030409","article-title":"Hyperlipidemia in liver transplant recipients: prevalence and risk factors","volume":"3","author":"Gisbert","year":"1997","journal-title":"Liver Transpl Surg"},{"issue":"6","key":"10.1016\/j.cld.2011.08.007_bib68","first-page":"1381","article-title":"Bile acid metabolism and biliary secretion in patients receiving orthotopic liver transplants: differing effects of cyclosporine and FK 506","volume":"19","author":"McCashland","year":"1994","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2011.08.007_bib69","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/hep.510240325","article-title":"Cyclosporine inhibits catabolism of low-density lipoproteins in HepG2 cells by about 25%","volume":"24","author":"Rayyes","year":"1996","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2011.08.007_bib70","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1053\/jlts.2001.23916","article-title":"Dyslipidemia during sirolimus therapy in liver transplant recipients occurs with concomitant cyclosporine but not tacrolimus","volume":"7","author":"Trotter","year":"2001","journal-title":"Liver Transpl"},{"issue":"Suppl 3","key":"10.1016\/j.cld.2011.08.007_bib71","doi-asserted-by":"crossref","first-page":"143S","DOI":"10.1016\/S0041-1345(03)00233-1","article-title":"Sirolimus changes lipid concentrations and lipoprotein metabolism in kidney transplant recipients","volume":"35","author":"Morrisett","year":"2003","journal-title":"Transplant Proc"},{"issue":"3","key":"10.1016\/j.cld.2011.08.007_bib72","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jacc.2004.07.001","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines","volume":"44","author":"Grundy","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.cld.2011.08.007_bib73","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/00007890-199610150-00011","article-title":"Hyperlipidemia after liver transplantation: natural history and treatment with the hydroxy-methylglutaryl-coenzyme A reductase inhibitor pravastatin","volume":"62","author":"Imagawa","year":"1996","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.cld.2011.08.007_bib74","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2165\/00003495-200363040-00003","article-title":"Interactions between cyclosporin and lipid-lowering drugs: implications for organ transplant recipients","volume":"63","author":"Asberg","year":"2003","journal-title":"Drugs"},{"issue":"11","key":"10.1016\/j.cld.2011.08.007_bib75","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1097\/00007890-199612150-00005","article-title":"Evaluation of fluvastatin in the treatment of hypercholesterolemia in renal transplant recipients taking cyclosporine","volume":"62","author":"Goldberg","year":"1996","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.cld.2011.08.007_bib76","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1053\/jlts.2001.24637","article-title":"Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight","volume":"7","author":"Neal","year":"2001","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.cld.2011.08.007_bib77","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/01.tp.0000203167.77570.11","article-title":"Ezetimibe in renal transplant patients with hyperlipidemia resistant to HMG-CoA reductase inhibitors","volume":"81","author":"Langone","year":"2006","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.cld.2011.08.007_bib78","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/lt.21710","article-title":"Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia","volume":"15","author":"Almutairi","year":"2009","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.cld.2011.08.007_bib79","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1185\/030079906X89766","article-title":"Evaluation of the safety and tolerability of prolonged-release nicotinic acid in a usual care setting: the NAUTILUS study","volume":"22","author":"Vogt","year":"2006","journal-title":"Curr Med Res Opin"},{"issue":"Suppl","key":"10.1016\/j.cld.2011.08.007_bib80","first-page":"31","article-title":"American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis","volume":"16","author":"Watts","year":"2010","journal-title":"Endocr Pract"},{"issue":"4","key":"10.1016\/j.cld.2011.08.007_bib81","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/hep.21805","article-title":"Fractures and avascular necrosis before and after orthotopic liver transplantation: long-term follow-up and predictive factors","volume":"46","author":"Guichelaar","year":"2007","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.cld.2011.08.007_bib82","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/lt.20874","article-title":"Bone mineral density before and after OLT: long-term follow-up and predictive factors","volume":"12","author":"Guichelaar","year":"2006","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.cld.2011.08.007_bib83","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.1840140215","article-title":"Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis","volume":"14","author":"Eastell","year":"1991","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2011.08.007_bib84","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1007\/s00198-006-0082-5","article-title":"Effects of alendronate on bone mineral density and bone metabolic markers in patients with liver transplantation","volume":"17","author":"Atamaz","year":"2006","journal-title":"Osteoporos Int"},{"issue":"5","key":"10.1016\/j.cld.2011.08.007_bib85","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/lt.500050507","article-title":"Evidence of continuing bone recovery at a mean of 7 years after liver transplantation","volume":"5","author":"Feller","year":"1999","journal-title":"Liver Transpl Surg"},{"issue":"6","key":"10.1016\/j.cld.2011.08.007_bib86","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s001980170094","article-title":"Bone disease after liver transplantation: a long-term prospective study of bone mass changes, hormonal status and histomorphometric characteristics","volume":"12","author":"Monegal","year":"2001","journal-title":"Osteoporos Int"},{"issue":"4","key":"10.1016\/j.cld.2011.08.007_bib87","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1053\/jlts.2003.50044","article-title":"Osteoporosis after liver transplantation","volume":"9","author":"Compston","year":"2003","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.cld.2011.08.007_bib88","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/hep.21852","article-title":"Bone disorders in chronic liver disease","volume":"46","author":"Collier","year":"2007","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2011.08.007_bib89","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.abb.2010.05.030","article-title":"Liver and bone","volume":"503","author":"Guanabens","year":"2010","journal-title":"Arch Biochem Biophys"},{"issue":"6","key":"10.1016\/j.cld.2011.08.007_bib90","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00223-001-2028-4","article-title":"High prevalence of osteoporosis in patients with chronic liver disease prior to liver transplantation","volume":"69","author":"Ninkovic","year":"2001","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"10.1016\/j.cld.2011.08.007_bib91","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF02678145","article-title":"Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporine A","volume":"68","author":"Monegal","year":"2001","journal-title":"Calcif Tissue Int"},{"issue":"12","key":"10.1016\/j.cld.2011.08.007_bib92","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1097\/TP.0b013e3181ff8794","article-title":"Early steroid-free immunosuppression with FK506 after liver transplantation: long-term results of a prospectively randomized double-blinded trial","volume":"90","author":"Weiler","year":"2010","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.cld.2011.08.007_bib93","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1359\/jbmr.2001.16.1.72","article-title":"Immunosuppressant use without bone loss\u2013implications for bone loss after transplantation","volume":"16","author":"Goodman","year":"2001","journal-title":"J\u00a0Bone Miner Res"},{"issue":"2","key":"10.1016\/j.cld.2011.08.007_bib94","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00007890-199801270-00025","article-title":"Mycophenolate mofetil: a promising new immunosuppressant that does not cause bone loss in the rat","volume":"65","author":"Dissanayake","year":"1998","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.cld.2011.08.007_bib95","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1432-2277.2009.00976.x","article-title":"Effect of bisphosphonates on bone mineral density in liver transplant patients: a meta-analysis and systematic review of randomized controlled trials","volume":"23","author":"Kasturi","year":"2010","journal-title":"Transpl Int"},{"issue":"4","key":"10.1016\/j.cld.2011.08.007_bib96","doi-asserted-by":"crossref","first-page":"239","DOI":"10.7326\/0003-4819-144-4-200602210-00005","article-title":"Zoledronic acid prevents bone loss after liver transplantation: a randomized, double-blind, placebo-controlled trial","volume":"144","author":"Crawford","year":"2006","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.cld.2011.08.007_bib97","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1432-2277.2010.01061.x","article-title":"Treatment of osteoporosis after liver transplantation with ibandronate","volume":"23","author":"Kaemmerer","year":"2010","journal-title":"Transpl Int"},{"issue":"2","key":"10.1016\/j.cld.2011.08.007_bib98","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1432-2277.2008.00763.x","article-title":"Pamidronate in the prevention of bone loss after liver transplantation: a randomized controlled trial","volume":"22","author":"Monegal","year":"2009","journal-title":"Transpl Int"},{"issue":"9","key":"10.1016\/j.cld.2011.08.007_bib99","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/j.1478-3231.2010.02303.x","article-title":"Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review","volume":"30","author":"Chak","year":"2010","journal-title":"Liver Int"},{"issue":"12","key":"10.1016\/j.cld.2011.08.007_bib100","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1046\/j.1600-6143.2003.00245.x","article-title":"Tumors and transplantation: the 2003 Third Annual ASTS State-of-the-Art Winter Symposium","volume":"3","author":"Feng","year":"2003","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.cld.2011.08.007_bib101","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/01.TP.0000173775.16579.18","article-title":"Incidence of cancers following orthotopic liver transplantation in a single center: comparison with national cancer incidence rates for England and Wales","volume":"80","author":"Oo","year":"2005","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.cld.2011.08.007_bib102","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1432-2277.2003.tb00363.x","article-title":"Rapid development of esophageal squamous cell carcinoma after liver transplantation for alcohol-induced cirrhosis","volume":"16","author":"Kenngott","year":"2003","journal-title":"Transpl Int"},{"issue":"9103","key":"10.1016\/j.cld.2011.08.007_bib103","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0140-6736(97)08496-1","article-title":"Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens","volume":"351","author":"Dantal","year":"1998","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.cld.2011.08.007_bib104","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1093\/ndt\/gfp425","article-title":"Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma","volume":"25","author":"Ingvar","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.cld.2011.08.007_bib105","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0168-8278(00)00077-5","article-title":"Increased cancer risk after liver transplantation: a population-based study","volume":"34","author":"Haagsma","year":"2001","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2011.08.007_bib106","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/(SICI)1097-0142(19970915)80:6<1141::AID-CNCR18>3.0.CO;2-8","article-title":"De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin","volume":"80","author":"Jonas","year":"1997","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.cld.2011.08.007_bib107","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1111\/j.1600-6143.2005.01117.x","article-title":"Addition of MMF to dual immunosuppression does not increase the risk of malignant short-term death after liver transplantation","volume":"5","author":"Lake","year":"2005","journal-title":"Am J Transplant"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2011.08.007_bib108","doi-asserted-by":"crossref","first-page":"i11","DOI":"10.1093\/ndt\/gfm084","article-title":"The role of proliferation signal inhibitors in post-transplant malignancies","volume":"22","author":"Gutierrez-Dalmau","year":"2007","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"10.1016\/j.cld.2011.08.007_bib109","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/lt.20525","article-title":"Nonmelanoma skin cancer after liver transplantation. Study of risk factors","volume":"11","author":"Herrero","year":"2005","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.cld.2011.08.007_bib110","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1053\/jlts.2002.29350","article-title":"De novo tumors after liver transplantation: a single-institution experience","volume":"8","author":"Sanchez","year":"2002","journal-title":"Liver Transpl"},{"issue":"17","key":"10.1016\/j.cld.2011.08.007_bib111","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJMra022137","article-title":"Skin cancers after organ transplantation","volume":"348","author":"Euvrard","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.cld.2011.08.007_bib112","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.transproceed.2009.03.079","article-title":"De novo tumors are a major cause of late mortality after orthotopic liver transplantation","volume":"41","author":"Baccarani","year":"2009","journal-title":"Transplant Proc"},{"issue":"Suppl","key":"10.1016\/j.cld.2011.08.007_bib113","first-page":"378","article-title":"Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study","volume":"161","author":"Ulrich","year":"2009","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.cld.2011.08.007_bib114","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/00007890-200011150-00012","article-title":"Long-term follow-up after liver transplantation for alcoholic liver disease under tacrolimus","volume":"70","author":"Jain","year":"2000","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.cld.2011.08.007_bib115","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/00007890-199902150-00014","article-title":"Increased incidence of oropharyngeal squamous cell carcinomas after liver transplantation for alcoholic cirrhosis","volume":"67","author":"Duvoux","year":"1999","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.cld.2011.08.007_bib116","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/lt.500050405","article-title":"Rapid progression to high-grade dysplasia in Barrett\u2019s esophagus after liver transplantation","volume":"5","author":"Trotter","year":"1999","journal-title":"Liver Transpl Surg"},{"issue":"6","key":"10.1016\/j.cld.2011.08.007_bib117","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1016\/j.transproceed.2009.06.153","article-title":"Malignancy after liver transplantation: cumulative risk for development","volume":"41","author":"Marques","year":"2009","journal-title":"Transplant Proc"},{"issue":"6","key":"10.1016\/j.cld.2011.08.007_bib118","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1016\/j.transproceed.2009.06.022","article-title":"Non-skin solid tumors as a cause of morbidity and mortality after liver transplantation","volume":"41","author":"Fraile","year":"2009","journal-title":"Transplant Proc"},{"issue":"4","key":"10.1016\/j.cld.2011.08.007_bib119","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1600-6143.2010.03049.x","article-title":"Risk of colorectal carcinoma in post-liver transplant patients: a systematic review and meta-analysis","volume":"10","author":"Sint","year":"2010","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.cld.2011.08.007_bib120","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/hep.1840110320","article-title":"Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis","volume":"11","author":"Higashi","year":"1990","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.cld.2011.08.007_bib121","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1111\/j.1600-6143.2009.02733.x","article-title":"Long-term management of the liver transplant patient: recommendations for the primary care doctor","volume":"9","author":"McGuire","year":"2009","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.cld.2011.08.007_bib122","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2036.2006.03166.x","article-title":"Review article: medical management of the liver transplant recipient\u2014a primer for non-transplant doctors","volume":"25","author":"Sethi","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.cld.2011.08.007_bib123","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1097\/00007890-199911270-00015","article-title":"Epstein-Barr virus-induced posttransplant lymphoproliferative disorders","volume":"68","author":"Paya","year":"1999","journal-title":"Transplantation"},{"issue":"5 Pt 1","key":"10.1016\/j.cld.2011.08.007_bib124","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1600-6143.2006.01294.x","article-title":"Post-transplant lymphoproliferative disorders following liver transplantation: incidence, risk factors and survival","volume":"6","author":"Kremers","year":"2006","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.cld.2011.08.007_bib125","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/01.meg.0000231752.50587.ae","article-title":"Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection?","volume":"18","author":"Burra","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2011.08.007_bib126","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/lt.500050310","article-title":"Posttransplantation lymphoproliferative disorder in liver recipients: characteristics, management, and outcome","volume":"5","author":"Ben Ari","year":"1999","journal-title":"Liver Transpl Surg"},{"issue":"6","key":"10.1016\/j.cld.2011.08.007_bib127","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0168-8278(97)80145-6","article-title":"The clinical diversity and role of chemotherapy in lymphoproliferative disorder in liver transplant recipients","volume":"27","author":"McCarthy","year":"1997","journal-title":"J\u00a0Hepatol"},{"issue":"8377","key":"10.1016\/j.cld.2011.08.007_bib128","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0140-6736(84)90994-2","article-title":"Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy","volume":"1","author":"Starzl","year":"1984","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.cld.2011.08.007_bib129","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00007890-200210270-00007","article-title":"Lymphomas occurring late after solid-organ transplantation: influence of treatment on the clinical outcome","volume":"74","author":"Dotti","year":"2002","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.cld.2011.08.007_bib130","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1399-0012.2008.00927.x","article-title":"Usefulness of a program of neoplasia surveillance in liver transplantation. A preliminary report","volume":"23","author":"Herrero","year":"2009","journal-title":"Clin Transplant"},{"issue":"10","key":"10.1016\/j.cld.2011.08.007_bib131","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1111\/j.1600-6143.2009.02766.x","article-title":"Extensive surveillance promotes early diagnosis and improved survival of de novo malignancies in liver transplant recipients","volume":"9","author":"Finkenstedt","year":"2009","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.cld.2011.08.007_bib132","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s11605-007-0084-4","article-title":"A\u00a030-year analysis of colorectal adenocarcinoma in transplant recipients and proposal for altered screening","volume":"11","author":"Johnson","year":"2007","journal-title":"J\u00a0Gastrointest Surg"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326111000997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326111000997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T02:20:32Z","timestamp":1741918832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326111000997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":132,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S1089326111000997"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2011.08.007","relation":{},"ISSN":["1089-3261"],"issn-type":[{"type":"print","value":"1089-3261"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}